HYBRID EVENT: You can participate in person at Singapore or Virtually from your home or work.
2nd Edition of International Cancer Research Conference
March 19-21, 2026 | Singapore
Cancer Biology
Cancer Biology
- Genomic Instability and Mutations
- Epigenetics and Gene Regulation
- Tumor Microenvironment and Cellular Interactions
- Cell Signaling Pathways in Cancer
- Metabolism and Cancer
- Cancer Stem Cells and Tumor Heterogeneity
- Mechanisms of Metastasis
- Cell Death and Survival Pathways
Cancer biology is the study of the molecular and cellular mechanisms that drive cancer development and progression. Researchers focus on how genetic mutations, environmental factors, and lifestyle choices interact to cause normal cells to transform into malignant ones. Key areas of cancer biology include the study of oncogenes, tumor suppressor genes, and the tumor microenvironment. These discoveries help scientists understand how cancer cells evade the immune system, resist treatments, and spread to other parts of the body. Ongoing research in cancer biology aims to develop targeted therapies that can more effectively treat different cancer types with fewer side effects.
Committee Members
Rajvir Dahiya
University of California San Francisco, United States
Anyou Wang
DIFIBER LLC, United States
Michael Thompson
University of Toronto, Canada Cancer Research 2026 Speakers
Can Küçük
Dokuz Eylul University, Turkey
Nadia Leney Olazo Marquez
Benemérita Universidad Autónoma de Puebla, Mexico
Liu Ying
Shanghai University, China
Ratan Kumar Sarkar
Independent Researcher, IndiaSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : Uncovering tumor-suppressive roles of histone modifiers in gastric cancer through spatial transcriptomics and epigenomics
Shilpa S Dhar, UT MD Anderson Cancer Center, United States
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : A case-based approach using IMPeTUs criteria in FDG PET/CT reporting of multiple myeloma
Mudalsha Ravina, All India Institute of Medical Sciences, India
Title : Transforming cancer care: Innovations, integrations, and impact
Shayan Maqsood, Jamia Hamdard University, India
Title : Updates on controversies surrounding the staging and management of newly diagnosed localized prostate cancer using prostate-specific membrane antigen (PSMA) positron emission tomography
Patricia Tai, University of Saskatchewan, Canada